133 related articles for article (PubMed ID: 36529126)
1. Expression of Wilms' Tumor 1 Antigen, Vimentin, and Corticotropin-Releasing Factor in the Human Kidney with Focal Segmental Glomerulosclerosis and Effect of Oxidative Stress on These Markers in HEK 293 Cells.
Csurgyók R; Sütő G; Wittmann I; Vas T
Kidney Blood Press Res; 2023; 48(1):56-65. PubMed ID: 36529126
[TBL] [Abstract][Full Text] [Related]
2. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1.
Gebeshuber CA; Kornauth C; Dong L; Sierig R; Seibler J; Reiss M; Tauber S; Bilban M; Wang S; Kain R; Böhmig GA; Moeller MJ; Gröne HJ; Englert C; Martinez J; Kerjaschki D
Nat Med; 2013 Apr; 19(4):481-7. PubMed ID: 23502960
[TBL] [Abstract][Full Text] [Related]
3. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
4. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
6. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor and glomerular disease. Occurrence with features of membranoproliferative glomerulonephritis and secondary focal, segmental glomerulosclerosis.
Thorner P; McGraw M; Weitzman S; Balfe JW; Klein M; Baumal R
Arch Pathol Lab Med; 1984 Feb; 108(2):141-6. PubMed ID: 6320757
[TBL] [Abstract][Full Text] [Related]
8. Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis.
Ikezumi Y; Suzuki T; Karasawa T; Yamada T; Hasegawa H; Nishimura H; Uchiyama M
Am J Nephrol; 2013; 38(2):149-57. PubMed ID: 23920104
[TBL] [Abstract][Full Text] [Related]
9. Influence of bushenhuoxue on podocytes of focal segmental glomerulosclerosis mice.
Zuo C; Tan X; Jia S; Zhang M; Zhang D
J Tradit Chin Med; 2014 Oct; 34(5):591-6. PubMed ID: 25417411
[TBL] [Abstract][Full Text] [Related]
10. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis.
Ohtaka A; Ootaka T; Sato H; Soma J; Sato T; Saito T; Ito S
Am J Kidney Dis; 2002 Mar; 39(3):475-85. PubMed ID: 11877566
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?
Ohtaka A; Ootaka T; Sato H; Ito S
Nephrol Dial Transplant; 2002; 17 Suppl 9():11-5. PubMed ID: 12386275
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
13. A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.
Hall G; Gbadegesin RA; Lavin P; Wu G; Liu Y; Oh EC; Wang L; Spurney RF; Eckel J; Lindsey T; Homstad A; Malone AF; Phelan PJ; Shaw A; Howell DN; Conlon PJ; Katsanis N; Winn MP
J Am Soc Nephrol; 2015 Apr; 26(4):831-43. PubMed ID: 25145932
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
15. Dystroglycan in the diagnosis of FSGS.
Giannico G; Yang H; Neilson EG; Fogo AB
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1747-53. PubMed ID: 19808230
[TBL] [Abstract][Full Text] [Related]
16. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
17. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
19. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
Hill GS; Karoui KE; Karras A; Mandet C; Van Huyen JD; Nochy D; Bruneval P
Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
[TBL] [Abstract][Full Text] [Related]
20. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
